Vicore Pharma Holding
VCRE
5 hedge funds and large institutions have $13.6M invested in Vicore Pharma Holding in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
5.06% more ownership
Funds ownership: 0% → 5.06% (+5.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Folketrygdfondet
Oslo Norway,
Norway
|
+$11.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$4.17M |
| 3 |
ADAR1 Capital Management
Austin,
Texas
|
+$926K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$147K |
| 5 |
JP Morgan Chase
New York
|
+$35 |
Top Sellers
VCRE Hedge Fund Activity: Q3 2026 in Review
5 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Vicore Pharma Holding (VCRE) for Q3 2026, worth a combined $13.6M.
Buyers outnumbered sellers: 5 funds opened new VCRE positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Folketrygdfondet, opening a new position worth an estimated $11.3M.
- 5 institutional investors held Vicore Pharma Holding (VCRE) as of Q3 2026, up from 0 in Q2 2026.
- Funds reported $13.6M of Vicore Pharma Holding stock for Q3 2026.
- 5 funds opened new Vicore Pharma Holding positions in Q3 2026 and 0 closed out, a net change of +5 holders.
- The largest Vicore Pharma Holding buyer in Q3 2026 was Folketrygdfondet, an estimated $11.3M added.
Based on aggregated 13F filings for Q3 2026.